Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$335M |
| 2 |
Exelon
EXC
|
+$314M |
| 3 |
Procter & Gamble
PG
|
+$241M |
| 4 |
TripAdvisor
TRIP
|
+$208M |
| 5 |
Starbucks
SBUX
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$551M |
| 2 |
Target
TGT
|
+$514M |
| 3 |
CELG
Celgene Corp
CELG
|
+$495M |
| 4 |
Cigna
CI
|
+$369M |
| 5 |
Costco
COST
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.21% |
| 2 | Healthcare | 19.58% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Industrials | 9.29% |
| 5 | Financials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Teladoc Health
TDOC
$1.13B
| $1.19M | ﹤0.01% |
21,404
-980
| -4% | -$59.8K |
|
1502
Campbell Soup
CPB
$7.2B
| $1.19M | ﹤0.01% |
31,338
-66,017
| -68% | -$2.33M |
|
1503
Choice Hotels
CHH
$5B
| $1.18M | ﹤0.01% |
15,228
+104
| +0.7% | +$8.08K |
|
1504
Unitil
UTL
$977M
| $1.18M | ﹤0.01% |
21,847
+3,584
| +20% | +$187K |
|
1505
Haverty Furniture Companies
HVT
$430M
| $1.18M | ﹤0.01% |
53,764
-33,317
| -38% | -$720K |
|
|
CVET
1506
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.17M | ﹤0.01% |
+36,677
| New | +$1.3M |
|
|
HTLF
1507
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.17M | ﹤0.01% |
27,341
-47,252
| -63% | -$2.19M |
|
|
MRTX
1508
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.16M | ﹤0.01% |
15,875
-58,336
| -79% | -$3.97M |
|
|
WOW
1509
DELISTED
WideOpenWest
WOW
| $1.16M | ﹤0.01% |
+127,012
| New | +$1.04M |
|
|
CBPX
1510
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $1.16M | ﹤0.01% |
46,628
-204,808
| -81% | -$5.39M |
|
|
DOOR
1511
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.15M | ﹤0.01% |
23,064
-16,355
| -41% | -$870K |
|
1512
Primoris Services
PRIM
$4.04B
| $1.15M | ﹤0.01% |
55,352
-23,254
| -30% | -$489K |
|
1513
Future Fuel
FF
$241M
| $1.14M | ﹤0.01% |
85,399
+33,207
| +64% | +$564K |
|
1514
TTM Technologies
TTMI
$11.3B
| $1.14M | ﹤0.01% |
97,556
| – | – |
|
1515
J.M. Smucker
SJM
$13.5B
| $1.14M | ﹤0.01% |
9,822
-35,526
| -78% | -$3.71M |
|
1516
Rexford Industrial Realty
REXR
$8.4B
| $1.14M | ﹤0.01% |
31,683
+19,303
| +156% | +$650K |
|
1517
Cannae Holdings
CNNE
$668M
| $1.13M | ﹤0.01% |
46,757
-2,472
| -5% | -$52K |
|
|
PCH
1518
DELISTED
PotlatchDeltic
PCH
| $1.13M | ﹤0.01% |
29,915
-377
| -1% | -$13.5K |
|
1519
Rayonier Advanced Materials
RYAM
$563M
| $1.13M | ﹤0.01% |
83,012
-10,664
| -11% | -$144K |
|
1520
Bank of Marin Bancorp
BMRC
$439M
| $1.12M | ﹤0.01% |
27,622
-3,866
| -12% | -$164K |
|
1521
Corpay
CPAY
$27.2B
| $1.12M | ﹤0.01% |
4,554
-2,210
| -33% | -$478K |
|
1522
Tesla
TSLA
$1.38T
| $1.11M | ﹤0.01% |
60,090
+45,600
| +315% | +$915K |
|
|
SEM
1523
DELISTED
Select Medical
SEM
| $1.11M | ﹤0.01% |
146,630
+71,666
| +96% | +$576K |
|
|
VIVO
1524
DELISTED
Meridian Bioscience Inc
VIVO
| $1.11M | ﹤0.01% |
62,926
+13,690
| +28% | +$228K |
|
1525
Brighthouse Financial
BHF
$2.98B
| $1.1M | ﹤0.01% |
30,450
-2,109
| -6% | -$79K |
|
Similar funds
Cliff Asness's Q1 2019 Portfolio in Review
As of Q1 2019, Cliff Asness held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Cliff Asness's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
- Cliff Asness added most to Biogen in Q1 2019, an estimated $335M increase.
- Cliff Asness's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
- Cliff Asness fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
- Cliff Asness's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
- Cliff Asness opened 140 new positions and closed 155 in Q1 2019.
- Cliff Asness's portfolio value rose 9.2% quarter-over-quarter to $94.3B.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.